ENTBF - Entheon Biomedical Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.10M
Enterprise Value 737.48k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)4.82
Price/Book (mrq)2.87
Enterprise Value/Revenue 2.38
Enterprise Value/EBITDA -0.34

Trading Information

Stock Price History

Beta (5Y Monthly) 1.80
52-Week Change 3-62.00%
S&P500 52-Week Change 314.65%
52 Week High 30.0810
52 Week Low 30.0100
50-Day Moving Average 30.0199
200-Day Moving Average 30.0253

Share Statistics

Avg Vol (3 month) 310.98k
Avg Vol (10 day) 339.45k
Shares Outstanding 559.09M
Implied Shares Outstanding 6N/A
Float 857.19M
% Held by Insiders 18.63%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 11, 2020
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Nov 29, 2022
Most Recent Quarter (mrq)Feb 27, 2023


Profit Margin 0.00%
Operating Margin (ttm)-706.07%

Management Effectiveness

Return on Assets (ttm)-30.39%
Return on Equity (ttm)-15.59%

Income Statement

Revenue (ttm)309.68k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)1,248.20%
Gross Profit (ttm)189.68k
Net Income Avi to Common (ttm)-613.61k
Diluted EPS (ttm)-0.0000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)504.72k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.29
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-967.27k
Levered Free Cash Flow (ttm)-1.36M